Universitätsklinikum Jena

Evaluation of integrated hpv dna as individualized biomarkers for the detection of recurrent cin2/3 during post-treatment surveillance (2021) Hoyer H, Mehlhorn G, Scheungraber C, Hagemann I, Hirchenhain C, Woelber L, Stolte C, et al. Journal article In vivo coherent anti-Stokes Raman scattering microscopy reveals vitamin A distribution in the liver (2021) Rodewald M, Bae H, Huschke S, Meyer-Zedler T, Schmitt M, Press AT, Schubert S, et al. Journal article EVALUATION OF A VIRTUAL REALITY-BASED APPLICATION TO EDUCATE HEALTHCARE PROFESSIONALS AND MEDICAL STUDENTS ABOUT INFLAMMATORY ARTHRITIS (2021) Klemm P, Kleyer A, Tascilar K, Schuster L, Meinderink T, Steiger F, Lange U, et al. Conference contribution, Abstract of a poster Re-Irradiation for Patients with Head and Neck Squamous Cell Carcinoma - A multicenter Analysis of 253 Patients of the jDEGRO Trial Group (2021) Roesch J, Oertel M, Dobiasch S, Fabian A, Fleischmann D, Von Der Gruen J, Hering D, et al. Conference contribution Thrombospondin‐2 and ldh are putative predictive biomarkers for treatment with everolimus in second‐line metastatic clear cell renal cell carcinoma (Marc‐2 study) (2021) Zeuschner P, Hölters S, Stöckle M, Seliger B, Mueller A, Bachmann HS, Grünwald V, et al. Journal article Telemedicine in stroke-pertinent to stroke care in Germany (2021) Barlinn J, Winzer S, Worthmann H, Urbanek C, Haeusler KG, Guenther A, Erdur H, et al. Journal article European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis (2021) Loman L, Uter W, Armario-Hita JC, Ayala F, Balato A, Ballmer-Weber BK, Bauer A, et al. Journal article Proposed definition of competencies for surgical neuro-oncology training (2021) Kamp MA, Malzkorn B, von Sass C, DiMeco F, Hadjipanayis CG, Senft C, Rapp M, et al. Journal article Neue Empfehlungen der STIKO zum Impfen im Alter (2021) Kwetkat A, Heppner HJ, Endre AS, Leischker AH Journal article Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia (2021) Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, et al. Journal article